CIK 0001944885 · Non-accelerated filer<br>Emerging growth company
Apollomics Inc.
Sign in to watch- Ticker
- APLM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 1-650-209-4055
- Business address
- 668 ARROW GRAND CIR, SUITE 206, COVINA, CA, 91772
Securities
- APLM Class A Ordinary Shares Nasdaq
- APLMW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | Chen Yi-Kuei Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-09-14 | LIN PETER KUAN-HOW Chief Financial Officer | Grant or award · Stock option (Right to Buy) | +6,000 | 6,000 | ||
| 2026-09-14 | Yen Hung Hsien Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2026-09-14 | LIN PETER KUAN-HOW Chief Financial Officer | Grant or award · Stock option (Right to Buy) | +6,000 | 6,000 | ||
| 2026-09-14 | CHEN HONG-JUNG Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2026-09-14 | Chen Yi-Kuei Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-09-14 | TSAI HSIEN-SHU Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2026-09-14 | Yen Hung Hsien Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2026-09-14 | Huang Ya-Chi Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2026-09-14 | Chen Hung-Wen Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2026-08-17 | Huang Ya-Chi Director | Option exercise | +500 | 1,500 | ||
| 2026-08-17 | Huang Ya-Chi Director | Option exercise · Restricted Stock Units | −500 | 500 | ||
| 2026-08-14 | Chen Yi-Kuei Chief Operating Officer | Purchase | +20,000 | $15.00 | $300K | 121,248 |
| 2026-08-14 | LIN PETER KUAN-HOW Chief Financial Officer | Purchase | +26,667 | $15.00 | $400K | 48,979 |
| 2026-08-14 | Chen Hung-Wen Chief Executive Officer | Purchase | +166,667 | $12.00 | $2.0M | 315,001 |
| 2026-08-14 | Chen Hung-Wen Chief Executive Officer | Purchase | +103,333 | $15.00 | $1.5M | 418,334 |
| 2026-08-14 | Chen Hung-Wen Chief Executive Officer | Purchase | +266,667 | $15.00 | $4.0M | 1,029,695 |
| 2026-06-15 | LIN PETER KUAN-HOW Chief Financial Officer | Option exercise | +10,000 | 25,900 | ||
| 2026-06-15 | LIN PETER KUAN-HOW Chief Financial Officer | Shares withheld for taxes | −3,588 | $13.85 | $50K | 22,312 |
| 2026-06-15 | LIN PETER KUAN-HOW Chief Financial Officer | Option exercise · Restricted Stock Units | −10,000 | 10,000 |
Page 2 of 3 · 55 trades